TOPLINEDanish pharma giant Novo Nordisk on Wednesday reported better-than-expected earnings for 2023, propelled by a tsunami of demand for its blockbuster weight loss and diabetes drugs as new treatments emerge and compete for a slice of the growing market.KEY FACTSNovo Nordisk reported $33.7 billion of sales for 2023, an increase of 36% at constant exchange […]
